ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $65,000 | +22.6% | 152,543 | +88.5% | 0.00% | – |
Q4 2016 | $53,000 | -79.8% | 80,943 | -2.8% | 0.00% | -100.0% |
Q3 2016 | $262,000 | +3.1% | 83,243 | +1.2% | 0.00% | 0.0% |
Q2 2016 | $254,000 | -17.8% | 82,243 | -3.5% | 0.00% | 0.0% |
Q1 2016 | $309,000 | -9.4% | 85,243 | +16.0% | 0.00% | 0.0% |
Q4 2015 | $341,000 | -22.5% | 73,476 | +1.7% | 0.00% | 0.0% |
Q3 2015 | $440,000 | -22.0% | 72,213 | +10.4% | 0.00% | 0.0% |
Q2 2015 | $564,000 | – | 65,413 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 1,900,000 | $16,378,000 | 3.36% |
Hilltop Park Associates LLC | 120,000 | $1,034,000 | 2.05% |
Abingworth LLP | 437,994 | $3,767,000 | 1.71% |
Sio Capital Management, LLC | 238,158 | $2,053,000 | 1.01% |
Rhenman & Partners Asset Management AB | 619,600 | $5,341,000 | 0.64% |
Broadfin Capital, LLC | 1,370,457 | $11,813,000 | 0.64% |
Perceptive Advisors | 1,202,156 | $10,363,000 | 0.62% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 931,257 | $8,027,000 | 0.60% |
WEXFORD CAPITAL LP | 177,500 | $1,530,000 | 0.41% |
Rock Springs Capital Management LP | 470,000 | $4,051,000 | 0.30% |